Amisulpride

Active ingredient description

Amisulpride is a neuroleptic. Amisulpride binds selectively with a high affinity to human dopaminergic D2/D3 receptor subtypes whereas it is devoid of affinity for D1, D4 and D5 receptor subtypes.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Amisulpride
N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides
Discover more medicines within N05AL05

Medicines

Amisulpride is the active ingredient of these drugs:

Drug
Countries

Cyprus Lithuania Netherlands

Australia Tunisia

Poland

Estonia Lithuania Poland

Poland

Spain

United States

Italy

Brazil

Tunisia

Australia Austria Cyprus Estonia France

Cyprus

Australia New Zealand

Poland

Tunisia

Tunisia

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 369.479 g/mol

External identifiers

CAS Substance: 71675-85-9
DrugBank Drug: DB06288
KEGG Drug: D07310
RxNorm Ingredient: 46303
SNOMED-CT Concept: 391761004
Amisulpride (substance)
UNII Identifier: 8110R61I4U
AMISULPRIDE